Patent · US Active

3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof

US11185537B2 · kind B2 · utility

3Cited by

5References

17Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Rohan Eric John Beckwith · Cambridge, US
Simone BONAZZI · Cambridge, US
Artiom CERNIJENKO · Cambridge, US
Fupeng Ma · Cambridge, US
Nathaniel F. Ware · Medford, US

Key dates

Filing date	Jul 8, 2019
Grant date	Nov 30, 2021
Priority date	—
Expiry date	Aug 18, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides a compound of Formula (I′):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.